Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;15(5):1203-1216.
doi: 10.5114/aoms.2018.79565. Epub 2018 Nov 13.

Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus

Affiliations

Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus

Yun-Sheng Wang et al. Arch Med Sci. 2019 Sep.

Abstract

Introduction: To investigate the serum retinol binding protein (RBP)-4, cystatin C (Cys C), homocysteine (HCY) and high-sensitivity C-reactive protein (hs-CRP) levels in newly diagnosed type 2 diabetes mellitus (NT2DM) patients, prediabetes mellitus (PDM) subjects and normal controls, as well as their correlation with clinical and laboratory indexes, such as blood pressure and lipoprotein.

Material and methods: A total of 242 subjects, including 141 NT2DM patients, 48 PDM subjects and 53 healthy controls, were recruited in the present study. Serum RBP-4, Cys C and hs-CRP concentrations were measured by enzyme-linked immunosorbent assay (ELISA). HCY concentration was determined by the chemical luminescence method.

Results: There were significant differences in Cys C and hs-CRP among NT2DM patients, PDM subjects and normal controls. In comparison to controls, there were significantly elevated Cys C and hs-CRP levels in PDM (both p < 0.001), and a significantly increased Cys C level in NT2DM (p < 0.001); however, there were no significant differences in Cys C and hs-CRP levels between NT2DM and PDM, and no significant differences of hs-CRP levels between NT2DM and normal controls. No significant differences of RBP-4 and HCY levels among NT2DM, PDM and normal control groups were observed.

Conclusions: Aberrant Cys C expression and its clinical associations in NT2DM suggest their important role in this disease.

Keywords: cystatin C; high-sensitivity C-reactive protein; homocysteine; retinol binding protein-4; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A – Receiver operating characteristic (ROC) curve analysis of Cys C for the discriminative ability of NT2DM patients versus healthy controls. B – Receiver operating characteristic (ROC) curve analysis of hs-CRP for the discriminative ability of NT2DM patients versus healthy controls
Figure 2
Figure 2
A – Receiver operating characteristic (ROC) curve analysis of Cys C for the discriminative ability of PDM subjects versus healthy controls. B – Receiver operating characteristic (ROC) curve analysis of hs-CRP for the discriminative ability of PDM subjects versus healthy controls

Similar articles

Cited by

References

    1. Lin Y, Sun Z. Current views on type 2 diabetes. J Endocrinol. 2010;204:1–11. - PMC - PubMed
    1. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes. 1997;46:1354–9. - PubMed
    1. Svensson AM, Miftaraj M, Franzen S, Eliasson B. Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study. Clin Diabetes Endocrinol. 2017;3:5. - PMC - PubMed
    1. Sun X, He J, Ji XL, et al. Association of chronic kidney disease with coronary heart disease and stroke risks in patients with type 2 diabetes mellitus: an observational cross-sectional study in Hangzhou, China. Chin Med J (Engl) 2017;130:57–63. - PMC - PubMed
    1. Patti AM, Al-Rasadi K, Giglio RV, et al. Natural approaches in metabolic syndrome management. Arch Med Sci. 2018;14:422–41. - PMC - PubMed